These innovative medications , Semaglutide , represent a remarkable advancement in managing type 2 diabetes and possibly related disorders. These drugs are classified as GLP-1 receptor agonists , meaning these substances to replicate the body's GLP-1 substance , boosting metabolic secretion and suppressing hunger . Despite Tirzepatide each works so